|
1
|
Greb JE, Goldminz AM, Elder JT, Lebwohl
MG, Gladman DD, Wu JJ, Mehta NN, Finlay AY and Gottlieb AB:
Psoriasis. Nat Rev Dis Primers. 2:160822016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Boehncke WH and Schön MP: Psoriasis.
Lancet. 386:983–994. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fülle M, Metze D, Böer-Auer A, Osada N and
Braun SA: Psoriasis on the leg: Site-specific histopathological and
immuno-histochemical features and diagnostic difficulties. Acta
Derm Venereol. 101:adv004532021.PubMed/NCBI
|
|
4
|
Ma F, Plazyo O, Billi AC, Tsoi LC, Xing X,
Wasikowski R, Gharaee-Kermani M, Hile G, Jiang Y, Harms PW, et al:
Single cell and spatial sequencing define processes by which
keratinocytes and fibroblasts amplify inflammatory responses in
psoriasis. Nat Commun. 14:34552023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Han Q, Niu X, Hou R, Li J, Liu Y, Li X, Li
J, Li Y, Zhang K and Wu Y: Dermal mesenchymal stem cells promoted
adhesion and migration of endothelial cells by integrin in
psoriasis. Cell Biol Int. 45:358–367. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Griffiths CEM, Armstrong AW, Gudjonsson JE
and Barker JNWN: Psoriasis. Lancet. 397:1301–1315. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Singh R, Koppu S, Perche PO and Feldman
SR: The cytokine mediated molecular pathophysiology of psoriasis
and its clinical implications. Int J Mol Sci. 22:127932021.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alajroush WA, Alrshid AI, Alajlan AH,
Alsalamah YB, Alhumaidan MI, Alhoumedan AI, Alrasheed MI,
Alowairdhi YA, Alowirdi F, Aljoufi AZ, et al: Psoriasis and
metabolic disorders: A comprehensive meta-analysis of million
adults worldwide. Cureus. 16:e520992024.PubMed/NCBI
|
|
9
|
Budu-Aggrey A, Brumpton B, Tyrrell J,
Watkins S, Modalsli EH, Celis-Morales C, Ferguson LD, Vie GÅ,
Palmer T, Fritsche LG, et al: Evidence of a causal relationship
between body mass index and psoriasis: A mendelian randomization
study. PLoS Med. 16:e10027392019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Leite BF, Morimoto MA, Gomes C, de
Carvalho Klemz BN, de Souza Genaro P, Damasceno NRT, Szejnfeld VL
and de Medeiros Pinheiro M: Higher bodily adiposity, fat intake,
and cholesterol serum levels are associated with higher disease
activity in psoriatic arthritis patients: Is there a link among fat
and skin and joint involvement? Lipids Health Dis. 19:212020.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park SH, Lee KA, Choi JH, Park S, Kim DW
and Jung SY: Impact of obesity on the IL-6 immune marker and Th17
immune cells in C57BL/6 mice models with imiquimod-induced
psoriasis. Int J Mol Sci. 24:55922023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Paroutoglou K, Papadavid E,
Christodoulatos GS and Dalamaga M: Deciphering the association
between psoriasis and obesity: Current evidence and treatment
considerations. Curr Obes Rep. 9:165–178. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Malavazos AE, Meregalli C, Sorrentino F,
Vignati A, Dubini C, Scravaglieri V, Basilico S, Boniardi F,
Spagnolo P, Malagoli P, et al: Semaglutide therapy decreases
epicardial fat inflammation and improves psoriasis severity in
patients affected by abdominal obesity and type-2 diabetes.
Endocrinol Diabetes Metab Case Rep. 2023:23–0017. 2023.PubMed/NCBI
|
|
14
|
Corbetta S, Angioni R, Cattaneo A,
Beck-Peccoz P and Spada A: Effects of retinoid therapy on insulin
sensitivity, lipid profile and circulating adipocytokines. Eur J
Endocrinol. 154:83–86. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Horwitz A and Birk R: Adipose tissue
hyperplasia and hypertrophy in common and syndromic obesity-the
case of BBS obesity. Nutrients. 15:34452023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Corvera S, Solivan-Rivera J and Loureiro
ZY: Angiogenesis in adipose tissue and obesity. Angiogenesis.
25:439–453. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kawai T, Autieri MV and Scalia R: Adipose
tissue inflammation and metabolic dysfunction in obesity. Am J
Physiol Cell Physiol. 320:C375–C391. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ruiz-Ojeda FJ, Méndez-Gutiérrez A,
Aguilera CM and Plaza-Díaz J: Extracellular matrix remodeling of
adipose tissue in obesity and metabolic diseases. Int J Mol Sci.
20:48882019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kiełbowski K, Bakinowska E, Ostrowski P,
Pala B, Gromowska E, Gurazda K, Dec P, Modrzejewski A and Pawlik A:
The role of adipokines in the pathogenesis of psoriasis. Int J Mol
Sci. 24:63902023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guan J, Feng J, Xu M, Liu M, He Y and Lu
F: Adipokines-enriched adipose extract restores skin barrier and
ameliorates inflammatory dysregulation in an atopic dermatitis
mouse model. Plast Reconstr Surg. 154:701e–712e. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Caton PW, Evans EA, Philpott MP and Hannen
RF: Can the skin make you fat? A role for the skin in regulating
adipose tissue function and whole-body glucose and lipid
homeostasis. Curr Opin Pharmacol. 37:59–64. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mizutani K, Shirakami E, Ichishi M,
Matsushima Y, Umaoka A, Okada K, Yamaguchi Y, Watanabe M, Morita E
and Yamanaka K: systemic dermatitis model mice exhibit atrophy of
visceral adipose tissue and increase stromal cells via skin-derived
inflammatory cytokines. Int J Mol Sci. 21:33672020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pestel J, Chehimi M, Bonhomme M, Robert M,
Vidal H and Eljaafari A: IL-17A contributes to propagation of
inflammation but does not impair adipogenesis and/or insulin
response, in adipose tissue of obese individuals. Cytokine.
126:1548652020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ueyama T, Sakuma M, Nakatsuji M, Uebi T,
Hamada T, Aiba A and Saito N: Rac-Dependent signaling from
keratinocytes promotes differentiation of intradermal white
adipocytes. J Invest Dermatol. 140:75–84.e6. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kovács D, Fazekas F, Oláh A and Törőcsik
D: Adipokines in the skin and in dermatological diseases. Int J Mol
Sci. 21:90482020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hwang J, Yoo JA, Yoon H, Han T, Yoon J, An
S, Cho JY and Lee J: The role of leptin in the association between
obesity and psoriasis. Biomol Ther (Seoul). 29:11–21. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Soujanya KV and Jayadeep AP:
Obesity-associated biochemical markers of inflammation and the role
of grain phytochemicals. J Food Biochem. 46:e142572022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wolf RM, Steele KE, Peterson LA, Magnuson
TH, Schweitzer MA and Wong GW: Lower circulating C1q/TNF-related
protein-3 (CTRP3) levels are associated with obesity: A
cross-sectional study. PLoS One. 10:e01339552015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Słuczanowska-Głabowska S, Staniszewska M,
Marchlewicz M, Duchnik E, Łuczkowska K, Safranow K, Machaliński B
and Pawlik A: Adiponectin, leptin and resistin in patients with
psoriasis. J Clin Med. 12:6632023. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gerdes S, Pinter A, Biermann M,
Papavassilis C and Reinhardt M: Adiponectin levels in a large
pooled plaque psoriasis study population. J Dermatolog Treat.
31:531–534. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shibata S, Tada Y, Hau CS, Mitsui A,
Kamata M, Asano Y, Sugaya M, Kadono T, Masamoto Y, Kurokawa M, et
al: Adiponectin regulates psoriasiform skin inflammation by
suppressing IL-17 production from γδ-T cells. Nat Commun.
6:76872015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gerdes S, Osadtschy S, Rostami-Yazdi M,
Buhles N, Weichenthal M and Mrowietz U: Leptin, adiponectin,
visfatin and retinol-binding protein-4-mediators of comorbidities
in patients with psoriasis? Exp Dermatol. 21:43–47. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Oh J, Lee Y, Oh SW, Li T, Shin J, Park SH
and Lee J: The role of adiponectin in the skin. Biomol Ther
(Seoul). 30:221–231. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kochumon S, Hasan A, Al-Rashed F, Sindhu
S, Thomas R, Jacob T, Al-Sayyar A, Arefanian H, Al Madhoun A,
Al-Ozairi E, et al: Increased adipose tissue expression of IL-23
associates with inflammatory markers in people with high LDL
cholesterol. Cells. 11:30722022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ohn J, Been KW, Kim JY, Kim EJ, Park T,
Yoon HJ, Ji JS, Okada-Iwabu M, Iwabu M, Yamauchi T, et al:
Discovery of a transdermally deliverable pentapeptide for
activating AdipoR1 to promote hair growth. EMBO Mol Med.
13:e137902021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Suh JH, Lee Y, Ohn J, Kim EJ, Kim TG, Jo
SJ, Kim SJ and Chung JH: Adiponectin-derived pentapeptide
ameliorates psoriasiform skin inflammation by suppressing IL-17
production in γδT cells. J Dermatol Sci. 106:45–52. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jin T, Sun Z, Chen X, Wang Y, Li R, Ji S
and Zhao Y: Serum human beta-defensin-2 is a possible biomarker for
monitoring response to JAK inhibitor in psoriasis patients.
Dermatology. 233:164–169. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tsang JYS, Li D, Ho D, Peng J, Xu A, Lamb
J, Chen Y and Tam PKH: Novel immunomodulatory effects of
adiponectin on dendritic cell functions. Int Immunopharmacol.
11:604–609. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
D'Amico F, Costantino G, Salvatorelli L,
Ramondetta A, De Pasquale R, Sortino MA and Merlo S: Inverse
correlation between the expression of AMPK/SIRT1 and NAMPT in
psoriatic skin: A pilot study. Adv Med Sci. 67:262–268. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shen H, Sha Y, Huang J, Mao AQ, Zhang T,
Wu MY, Sun F, Yu YY, Cheng ZQ and Gong YT: The roles of
AMPK-mediated autophagy and mitochondrial autophagy in a mouse
model of imiquimod-induced psoriasis. Am J Transl Res.
13:12626–12637. 2021.PubMed/NCBI
|
|
41
|
Wang R, Yu C, Tang Z, Sun J, Wang Y, Zhao
Z, Lin B and Li C: Leptin induces altered differentiation of
keratinocytes by inducing insulin resistance: Implications for
metabolic syndrome-induced resistance of psoriatic therapy. J
Dermatolog Treat. 35:23093052024. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhu KJ, Zhang C, Li M, Zhu CY, Shi G and
Fan YM: Leptin levels in patients with psoriasis: A meta-analysis.
Clin Exp Dermatol. 38:478–483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Johnston A, Arnadottir S, Gudjonsson JE,
Aphale A, Sigmarsdottir AA, Gunnarsson SI, Steinsson JT, Elder JT
and Valdimarsson H: Obesity in psoriasis: Leptin and resistin as
mediators of cutaneous inflammation. Br J Dermatol. 159:342–350.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Su X, Cheng Y and Chang D: The important
role of leptin in modulating the risk of dermatological diseases.
Front Immunol. 11:5935642020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Su X, Zhang G, Cheng Y and Wang B: Leptin
in skin disease modulation. Clin Chim Acta. 516:8–14. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yu Y, Liu Y, Shi FD, Zou H, Matarese G and
La Cava A: Cutting edge: Leptin-induced RORγt expression in CD4+ T
cells promotes Th17 responses in systemic lupus erythematosus. J
Immunol. 190:3054–3058. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Walendzik K, Kopcewicz M, Bukowska J,
Panasiewicz G, Szafranska B and Gawronska-Kozak B: The
transcription factor FOXN1 regulates skin adipogenesis and affects
susceptibility to diet-induced obesity. J Invest Dermatol.
140:1166–1175.e9. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
De Rosa V, Procaccini C, Calì G, Pirozzi
G, Fontana S, Zappacosta S, La Cava A and Matarese G: A key role of
leptin in the control of regulatory T cell proliferation. Immunity.
26:241–255. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang W, Zhang BT, Jiang QL, Zhao HQ, Xu Q,
Zeng Y, Xu JY and Jiang J: Leptin receptor antagonist attenuates
experimental autoimmune thyroiditis in mice by regulating Treg/Th17
cell differentiation. Front Endocrinol (Lausanne). 13:10425112022.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Calautti E, Avalle L and Poli V:
Psoriasis: A STAT3-centric view. Int J Mol Sci. 19:1712018.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Markaki A, Gkouskou K, Stylianou K,
Dermitzaki E, Perakis K, Margioris A and Daphnis E: Relationship
between adiposity, adipokines, inflammatory markers and lipid
profile in hemodialysis patients. Eur Rev Med Pharmacol Sci.
18:1496–1498. 2014.PubMed/NCBI
|
|
52
|
Ikeda K, Morizane S, Akagi T,
Hiramatsu-Asano S, Tachibana K, Yahagi A, Iseki M, Kaneto H, Wada
J, Ishihara K, et al: Obesity and dyslipidemia synergistically
exacerbate psoriatic skin inflammation. Int J Mol Sci. 23:43122022.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kanda N and Watanabe S: Leptin enhances
human beta-defensin-2 production in human keratinocytes.
Endocrinology. 149:5189–5198. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Khanna D, Khanna S, Khanna P, Kahar P and
Patel BM: Obesity: A chronic low-grade inflammation and its
markers. Cureus. 14:e227112022.PubMed/NCBI
|
|
55
|
Žužul K, Kunjko K, Milošević M, Tončić RJ,
Kelava T and Hadžavdić SL: The association between the severity of
psoriasis and obesity based on the analysis of visceral fat index
and serum levels of tumor necrosis factor-α, interleukin-6, and
resistin. Acta Dermatovenerol Croat. 30:8–17. 2022.PubMed/NCBI
|
|
56
|
Srikanth M and Rasool M: Resistin-A
plausible therapeutic target in the pathogenesis of psoriasis.
Immunol Invest. 53:115–159. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Shao S, Fang H, Dang E, Xue K, Zhang J, Li
B, Qiao H, Cao T, Zhuang Y, Shen S, et al: Neutrophil extracellular
traps promote inflammatory responses in psoriasis via activating
epidermal TLR4/IL-36R crosstalk. Front Immunol. 10:7462019.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Taouis M and Benomar Y: Is resistin the
master link between inflammation and inflammation-related chronic
diseases? Mol Cell Endocrinol. 533:1113412021. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Mahmoud MA, Mohamed RW, Attia FM, Atwa MA
and Abdel-Moneim SM: Expression of telomerase reverse transcriptase
in psoriatic lesional skin. Dis Markers. 22:265–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhang F, Li H, Zhou Y, Gu Y and Wang L:
Caveolin-1 expression in different types of psoriatic lesions:
Analysis of 66 cases. Indian J Dermatol. 59:225–229. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Huang TH, Lin CF, Alalaiwe A, Yang SC and
Fang JY: Apoptotic or antiproliferative activity of natural
products against keratinocytes for the treatment of psoriasis. Int
J Mol Sci. 20:25582019. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Chen SS, Tang CH, Chie MJ, Tsai CH, Fong
YC, Lu YC, Chen WC, Lai CT, Wei CY, Tai HC, et al: Resistin
facilitates VEGF-A-dependent angiogenesis by inhibiting miR-16-5p
in human chondrosarcoma cells. Cell Death Dis. 10:312019.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Sieminska I, Pieniawska M and Grzywa TM:
The immunology of psoriasis-current concepts in pathogenesis. Clin
Rev Allergy Immunol. 66:164–191. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Jang DI, Lee AH, Shin HY, Song HR, Park
JH, Kang TB, Lee SR and Yang SH: The role of tumor necrosis factor
alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in
therapeutics. Int J Mol Sci. 22:27192021. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Man AM, Orăsan MS, Hoteiuc OA,
Olănescu-Vaida-Voevod MC and Mocan T: Inflammation and psoriasis: A
comprehensive review. Int J Mol Sci. 24:160952023. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Patel AB, Tsilioni I, Weng Z and
Theoharides TC: TNF stimulates IL-6, CXCL8 and VEGF secretion from
human keratinocytes via activation of mTOR, inhibited by
tetramethoxyluteolin. Exp Dermatol. 27:135–143. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Tan JK, Aphale A, Malaviya R, Sun Y and
Gottlieb AB: Mechanisms of action of etanercept in psoriasis. J
Investig Dermatol Symp Proc. 12:38–45. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Johansen C, Funding AT, Otkjaer K,
Kragballe K, Jensen UB, Madsen M, Binderup L, Skak-Nielsen T,
Fjording MS and Iversen L: Protein expression of TNF-alpha in
psoriatic skin is regulated at a posttranscriptional level by
MAPK-activated protein kinase 2. J Immunol. 176:1431–1438. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
de Alcantara CC, Reiche EMV and Simão ANC:
Cytokines in psoriasis. Adv Clin Chem. 100:171–204. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Behfar S, Hassanshahi G, Nazari A and
Khorramdelazad H: A brief look at the role of monocyte
chemoattractant protein-1 (CCL2) in the pathophysiology of
psoriasis. Cytokine. 110:226–231. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Purzycka-Bohdan D, Nedoszytko B, Zabłotna
M, Gleń J, Szczerkowska-Dobosz A and Nowicki RJ: Chemokine profile
in psoriasis patients in correlation with disease severity and
pruritus. Int J Mol Sci. 23:133302022. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Chyl-Surdacka KM, Bartosińska J, Kowal M,
Przepiórka-Kosińska J, Krasowska D and Chodorowska G: Assessment of
visfatin concentrations in the serum of male psoriatic patients in
relation to metabolic abnormalities. Adv Clin Exp Med. 29:79–84.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Hau CS, Kanda N, Noda S, Tatsuta A, Kamata
M, Shibata S, Asano Y, Sato S, Watanabe S and Tada Y: Visfatin
enhances the production of cathelicidin antimicrobial peptide,
human β-defensin-2, human β-defensin-3, and S100A7 in human
keratinocytes and their orthologs in murine imiquimod-induced
psoriatic skin. Am J Pathol. 182:1705–1717. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Kanda N, Hau CS, Tada Y, Tatsuta A, Sato S
and Watanabe S: Visfatin enhances CXCL8, CXCL10, and CCL20
production in human keratinocytes. Endocrinology. 152:3155–3164.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Chyl-Surdacka KM, Gerkowicz A, Bartosińska
J, Kowal M, Przepiórka-Kosińska J, Surdacki G, Krasowska D and
Chodorowska G: Analysis of serum chemerin concentrations in
psoriatic patients in relation to metabolic abnormalities. Postepy
Dermatol Alergol. 36:531–537. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Wang Y, Huo J, Zhang D, Hu G and Zhang Y:
Chemerin/ChemR23 axis triggers an inflammatory response in
keratinocytes through ROS-sirt1-NF-κB signaling. J Cell Biochem.
120:6459–6470. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Zhang X, Yin M and Zhang LJ: Keratin 6, 16
and 17-critical barrier alarmin molecules in skin wounds and
psoriasis. Cells. 8:8072019. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Lynch M, Ahern T, Sweeney CM, Malara A,
Tobin AM, O'Shea D and Kirby B: Adipokines, psoriasis, systemic
inflammation, and endothelial dysfunction. Int J Dermatol.
56:1103–1118. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Xue K, Shao S, Fang H, Ma L, Li C, Lu Z
and Wang G: Adipocyte-derived CTRP3 exhibits anti-inflammatory
effects via LAMP1-STAT3 axis in psoriasis. J Invest Dermatol.
142:1349–1359.e8. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Wang K and Zeng C: Extracellular vesicles
and obesity. Adv Exp Med Biol. 1418:143–153. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Jeppesen DK, Zhang Q, Franklin JL and
Coffey RJ: Extracellular vesicles and nanoparticles: Emerging
complexities. Trends Cell Biol. 33:667–681. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Kumar V, Kiran S, Kumar S and Singh UP:
Extracellular vesicles in obesity and its associated inflammation.
Int Rev Immunol. 41:30–44. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Kranendonk MEG, Visseren FLJ, van
Herwaarden JA, Nolte-'t Hoen ENM, de Jager W, Wauben MHM and
Kalkhoven E: Effect of extracellular vesicles of human adipose
tissue on insulin signaling in liver and muscle cells. Obesity
(Silver Spring). 22:2216–2223. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Zhang X, Chen L, Xiao B, Liu H and Su Y:
Circ_0075932 in adipocyte-derived exosomes induces inflammation and
apoptosis in human dermal keratinocytes by directly binding with
PUM2 and promoting PUM2-mediated activation of AuroraA/NF-κB
pathway. Biochem Biophys Res Commun. 511:551–558. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Meybodi MA, Nilforoushzadeh MA,
KhandanDezfully N and Mansouri P: The safety and efficacy of
adipose tissue-derived exosomes in treating mild to moderate plaque
psoriasis: A clinical study. Life Sci. 353:1229152024. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Nussbaumerova B and Rosolova H: Obesity
and dyslipidemia. Curr Atheroscler Rep. 25:947–955. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Saalbach A, Seitz AT, Kohlmann J, Kalweit
L, Vogt L, Selig L, Engel KM and Simon JC: Modulation of dietary
fatty acids in an open-label study improves psoriasis and dampens
the inflammatory activation status. Nutrients. 15:16982023.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Herbert D, Franz S, Popkova Y, Anderegg U,
Schiller J, Schwede K, Lorz A, Simon JC and Saalbach A: High-Fat
diet exacerbates early psoriatic skin inflammation independent of
obesity: Saturated fatty acids as key players. J Invest Dermatol.
138:1999–2009. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Stelzner K, Herbert D, Popkova Y, Lorz A,
Schiller J, Gericke M, Klöting N, Blüher M, Franz S, Simon JC and
Saalbach A: Free fatty acids sensitize dendritic cells to amplify
TH1/TH17-immune responses. Eur J Immunol. 46:2043–2053. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Mogilenko DA, Haas JT, L'homme L, Fleury
S, Quemener S, Levavasseur M, Becquart C, Wartelle J, Bogomolova A,
Pineau L, et al: Metabolic and innate immune cues merge into a
specific inflammatory response via the UPR. Cell.
177:1201–1216.e19. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Lopes N, McIntyre C, Martin S, Raverdeau
M, Sumaria N, Kohlgruber AC, Fiala GJ, Agudelo LZ, Dyck L, Kane H,
et al: Distinct metabolic programs established in the thymus
control effector functions of γδ T cell subsets in tumor
microenvironments. Nat Immunol. 22:179–192. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Sivasami P, Elkins C, Diaz-Saldana PP,
Goss K, Peng A, Hamersky M IV, Bae J, Xu M, Pollack BP, Horwitz EM,
et al: Obesity-induced dysregulation of skin-resident PPARγ+ Treg
cells promotes IL-17A-mediated psoriatic inflammation. Immunity.
56:1844–1861.e6. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Cheung L, Fisher RM, Kuzmina N, Li D, Li
X, Werngren O, Blomqvist L, Ståhle M and Landén NX: Psoriasis skin
inflammation-induced microRNA-26b targets NCEH1 in underlying
subcutaneous adipose tissue. J Invest Dermatol. 136:640–648. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Zhu T, Yang S, Mauro TM and Man MQ:
Association of epidermal biophysical properties with obesity and
its implications. Skin Pharmacol Physiol. 36:165–173. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Arican O, Aral M, Sasmaz S and Ciragil P:
Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and
IL-18 in patients with active psoriasis and correlation with
disease severity. Mediators Inflamm. 2005:273–279. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Sehat M, Talaei R, Dadgostar E,
Nikoueinejad H and Akbari H: Evaluating serum levels of IL-33,
IL-36, IL-37 and gene expression of IL-37 in patients with
psoriasis vulgaris. Iran J Allergy Asthma Immunol. 17:179–187.
2018.PubMed/NCBI
|
|
97
|
Sharma N, Akkoyunlu M and Rabin RL:
Macrophages-common culprit in obesity and asthma. Allergy.
73:1196–1205. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Frühbeck G, Gómez-Ambrosi J, Ramírez B,
Mentxaka A, Rodríguez A, Becerril S, Reina G, Valentí V, Moncada R,
Silva C and Catalán V: Corrigendum: Increased levels of
interleukin-36 in obesity and type 2 diabetes fuels adipose tissue
inflammation by inducing its own expression and release by
adipocytes and macrophages. Front Immunol. 14:11383162023.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Mao Y, Hong KH, Liao W, Li L, Kim SJ,
Xiong Y, Nam IK, Choe SK and Kwak SA: Generation of a novel
transgenic zebrafish for studying adipocyte development and
metabolic control. Int J Mol Sci. 22:39942021. View Article : Google Scholar : PubMed/NCBI
|
